[HTML][HTML] The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel …

…, G Simoneau, E Vicaut, C Neut, B Flourié… - The American journal of …, 2004 - Elsevier
ABSTRACT Background Nondigestible carbohydrates (NDCHs) are fermented in the colon,
where they can selectively promote the growth of bifidobacteria. Objective Our aim was to …

[HTML][HTML] Administration of transgalacto-oligosaccharides increases fecal bifidobacteria and modifies colonic fermentation metabolism in healthy humans

Y Bouhnik, B Flourié, L D'Agay-Abensour… - The Journal of …, 1997 - Elsevier
Transgalacto-oligosaccharides are a mixture of oligosaccharides consisting of glucose and
galactose; they are not digested in the human small intestine. In vitro, they specifically …

Tolerance to low-digestible carbohydrates: symptomatology and methods

P Marteau, B Flourié - British Journal of Nutrition, 2001 - cambridge.org
Low-digestible carbohydrates (LDCs) are incompletely or not absorbed in the small bowel
and fermented in the colon. They are usually well tolerated but may also have some dose …

[HTML][HTML] Fetal death in utero and miscarriage in a patient with Crohn's disease under therapy with ustekinumab: case-report and review of the literature

…, M Chauvenet, C Bergoin, X Roblin, B Flourié… - BMC …, 2017 - Springer
Background Ustekinumab is a fully human monoclonal antibody against the p40 subunit of
interleukin (IL) 12 and 23 which is involved in the pathogenesis of several inflammatory …

Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome

Y Bouhnik, S Alain, A Attar, B Flourié… - Official journal of the …, 1999 - journals.lww.com
Objective: Small intestinal bacterial overgrowth syndrome (SIBOS) is characterized by an
abnormally high bacterial population level in the upper gut, exceeding 10 5 organisms/ml (5 …

Effects of fructo‐oligosaccharides ingestion on fecal bifidobacteria and selected metabolic indexes of colon carcinogenesis in healthy humans

Y Bouhnik, B Flourié, M Riottot, N Bisetti, MF Gailing… - 1996 - Taylor & Francis
Fructo‐oligosaccharides (FOS) are a mixture of oligosaccharides consisting of glucose
linked to fructose units. They are not digested in the human small intestine but fermented in …

Fibrin glue is effective healing perianal fistulas in patients with Crohn's disease

…, A Sénéjoux, V Vitton, L Gambiez, B Flourié… - Gastroenterology, 2010 - Elsevier
BACKGROUND & AIMS: Fibrin glue is a therapeutic for fistulas that activates thrombin to
form a fibrin clot, which mechanically seals the fistula tract. We assessed the efficacy and …

Small bowel adenocarcinoma in patients with Crohn's disease compared with small bowel adenocarcinoma de novo

…, AM Bouvier, J Cosnes, B Flourié… - Inflammatory bowel …, 2005 - academic.oup.com
Background Data concerning small bowel adenocarcinoma (SBA) in Crohn's disease (CD)
come from case reports and small retrospective series. The aim of this study was to further …

Antibiotic efficacy in small intestinal bacterial overgrowth–related chronic diarrhea: a crossover, randomized trial

A Attar, B Flourié, JC Rambaud, C Franchisseur… - Gastroenterology, 1999 - Elsevier
Background & Aims: No controlled trial has examined the clinical efficacy of antibiotics in
small bowel bacterial overgrowth. Methods: Ten patients with bacterial overgrowth–related …

A multicenter experience with infliximab for ulcerative colitis: outcomes and predictors of response, optimization, colectomy, and hospitalization

…, G Boschetti, S Nancey, J Filippi, B Flourié… - Official journal of the …, 2010 - journals.lww.com
OBJECTIVES: The objective of this study was to evaluate short-and long-term outcomes of
infliximab in ulcerative colitis (UC), including infliximab optimization, colectomy, and …